ClinConnect ClinConnect Logo
Search / Trial NCT07151547

Cut-Off Values for Gait and Balance in MS

Launched by HACETTEPE UNIVERSITY ·

Trial Information

Current as of October 17, 2025

Recruiting

Keywords

Cut Off Falls Gait Variability Limits Of Stability Postural Sways Multiple Sclerosis

ClinConnect Summary

This clinical trial is studying how walking patterns and balance can help predict the risk of falling in people with Multiple Sclerosis (MS). The researchers want to find specific measurements—called cut-off values—that can clearly show who is more likely to fall. By doing this, doctors and patients can take early steps to prevent falls and stay safer. The study will also compare which measurements—walking variability or balance tests—are better at identifying people with MS who are at risk of falling.

The trial is open to men and women between the ages of 65 and 74 who have MS. Participants can expect to undergo tests that measure how steady they are when standing and how their walking varies. These tests help the researchers understand the relationship between balance, walking, and fall risk. If you or a loved one fits the age range and has MS, this study might offer useful information to help manage fall risk through simple assessments.

Gender

ALL

Eligibility criteria

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Patients applied

0 patients applied

Trial Officials

Muhammed Kılınç

Principal Investigator

Hacettepe University

Ender Ayvat

Principal Investigator

Hacettepe University

Fatma Ayvat

Study Director

Hacettepe University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported